Cargando…

Role of SHP2/PTPN11 in the occurrence and prognosis of cancer: A systematic review and meta-analysis

Src homology-2 domain-containing protein tyrosine phosphatase (SHP2)/PTP non-receptor type 11 (PTPN11) have been reported to be expressed in a variety of solid tumors, though its role in tumors remains controversial. The aim of the present study was to explore the role of SHP2/PTPN11 in the occurren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shu, Wang, Xiaotong, Li, Qiuhong, Li, Chunli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713766/ https://www.ncbi.nlm.nih.gov/pubmed/36478896 http://dx.doi.org/10.3892/ol.2022.13605

Ejemplares similares

SHP2 is involved in the occurrence, development and prognosis of cancer
por: Li, Shu, et al.
Publicado: (2023)

Teasing apart the multiple roles of Shp2 (Ptpn11) in spermatogenesis
por: Maher, Geoffrey J, et al.
Publicado: (2019)

Prognostic significance of SHP2 (PTPN11) expression in solid tumors: A meta-analysis
por: Zhou, Jiupeng, et al.
Publicado: (2022)

Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis
por: Liu, Xia, et al.
Publicado: (2011)

Loss of Ptpn11 (Shp2) drives satellite cells into quiescence
por: Griger, Joscha, et al.
Publicado: (2017)

Targeted Ptpn11 deletion in mice reveals the essential role of SHP2 in osteoblast differentiation and skeletal homeostasis
por: Wang, Lijun, et al.
Publicado: (2021)

Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice
por: Sharma, Namit, et al.
Publicado: (2014)

The association between the methylation frequency of BRCA1/2 gene promoter and occurrence and prognosis of breast carcinoma: A meta-analysis
por: Li, Shu, et al.
Publicado: (2020)

Structural insights into Noonan/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11)
por: Qiu, Wei, et al.
Publicado: (2014)

An In Silico Study Investigating Camptothecin-Analog Interaction with Human Protein Tyrosine Phosphatase, SHP2 (PTPN11)
por: Bajia, Donald, et al.
Publicado: (2023)

Association of polymorphism of PTPN 11 encoding SHP-2 with gastric atrophy but not gastric cancer in Helicobacter pylori seropositive Chinese population
por: Jiang, Jing, et al.
Publicado: (2012)

PTPN11 (SHP2) Is Indispensable for Growth Factors and Cytokine Signal Transduction During Bovine Oocyte Maturation and Blastocyst Development
por: Idrees, Muhammad, et al.
Publicado: (2019)

Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder
por: Xu, Dan, et al.
Publicado: (2013)

The role of PTP1B (PTPN1) in the prognosis of solid tumors: A meta-analysis
por: Zhou, Jiupeng, et al.
Publicado: (2022)

Curcumin inhibits proliferation of hepatocellular carcinoma cells by blocking PTPN1 and PTPN11 expression
por: Zhang, Jingru, et al.
Publicado: (2023)

Non–lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells
por: Xu, Dan, et al.
Publicado: (2011)

Mutation of PTPN11 (Encoding SHP-2) Promotes MEK Activation and Malignant Progression in Neurofibromin-Deficient Cells in a Manner Sensitive to BRAP Mutation
por: Harigai, Ritsuko, et al.
Publicado: (2022)

Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations
por: Sheng, Li, et al.
Publicado: (2023)

Concomitant deletion of Ptpn6 and Ptpn11 in T cells fails to improve anticancer responses
por: Ventura, Pedro M O, et al.
Publicado: (2022)

Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)
por: Richards, Cathy E., et al.
Publicado: (2023)

Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations
por: Liu, Wei, et al.
Publicado: (2016)

PTPN11 hypomethylation is associated with gastric cancer progression
por: Xu, Lele, et al.
Publicado: (2020)

Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia
por: Liu, Yong, et al.
Publicado: (2023)

Noonan syndrome: rhGH treatment and PTPN11 mutation
por: Wu, Xian, et al.
Publicado: (2023)

PTK2 and PTPN11 expression in myelodysplastic syndromes
por: Lazarini, Mariana, et al.
Publicado: (2013)

KRAS Analysis in 34 Noonan Syndrome Patients without PTPN11 Mutation
por: Yamamoto, Kaoru, et al.
Publicado: (2007)

Distinct and Overlapping Functions of ptpn11 Genes in Zebrafish Development
por: Bonetti, Monica, et al.
Publicado: (2014)

Leukemogenic Ptpn11 Allele Causes Defective Erythropoiesis in Mice
por: Usenko, Tatiana, et al.
Publicado: (2014)

Activating Mutations in PTPN11 and KRAS in Canine Histiocytic Sarcomas
por: Takada, Marilia, et al.
Publicado: (2019)

PTPN11 Gene Mutations and Its Association with the Risk of Congenital Heart Disease
por: Xu, Zi-qing, et al.
Publicado: (2022)

The association of PTPN22 rs2476601 polymorphism and CTLA-4 rs231775 polymorphism with LADA risks: a systematic review and meta-analysis
por: Dong, Fang, et al.
Publicado: (2014)

Fgf2 and Ptpn11 play a role in cerebral injury caused by sevoflurane anesthesia
por: Zhang, Lin, et al.
Publicado: (2023)

LEOPARD syndrome in an infant with severe hypertrophic cardiomyopathy and PTPN11 mutation
por: Ganigara, Madhusudan, et al.
Publicado: (2011)

PTPN22 R620W Polymorphism is Associated with Myasthenia Gravis Risk: A Systematic Review and Meta-Analysis
por: Xiong, Xunbo, et al.
Publicado: (2015)

Genetic Variations of PTPN2 and PTPN22: Role in the Pathogenesis of Type 1 Diabetes and Crohn's Disease
por: Sharp, Robert C., et al.
Publicado: (2015)

High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma
por: Wang, Yu, et al.
Publicado: (2018)

Tumoral Prostate Shows Different Expression Pattern of Somatostatin Receptor 2 (SSTR2) and Phosphotyrosine Phosphatase SHP-1 (PTPN6) According to Tumor Progression
por: Cariaga-Martinez, Ariel Ernesto, et al.
Publicado: (2009)

A pan-cancer analysis confirms PTPN11’s potential as a prognostic and immunological biomarker
por: Cao, Yapeng, et al.
Publicado: (2022)

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
por: Jongmans, Marjolijn C J, et al.
Publicado: (2011)

Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia
por: Fobare, Sydney, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ohh4p9ilm7pcfe7lgq7mr4aqu7